Seok Jin Kim

机构：Samsung Medical Center, Abeona Therapeutics (United States), Sungkyunkwan University · ORCID：0000-0002-2776-4401

发表论文 690 篇 · 总被引 14559 次 · h-index 55

代表论文

• Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma (2025 · Blood · 被引 9)
• Different Level and Difficulties with Financial Burden in Multiple Myeloma Patients and Caregivers: A Dyadic Qualitative Study (2025 · Seminars in Oncology Nursing · 被引 7)
• Feasibility of Circulating Tumor DNA Detection in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement in Large B-Cell Lymphoma (2024 · Annals of Laboratory Medicine · 被引 5)
• Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma (2024 · Experimental Cell Research · 被引 5)
• Nivolumab in Relapsed or Refractory Primary Central Nervous System Lymphoma: Multicenter, Retrospective Study (2024 · Cancer Research and Treatment · 被引 5)
• Endoscopic Features of Gastrointestinal Amyloidosis: A Proposed Endoscopic Classification (2025 · Gut and Liver · 被引 4)